Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease

J J Soler-Cataluña, M A Martínez-García, P Román Sánchez, E Salcedo, M Navarro, R Ochando, J J Soler-Cataluña, M A Martínez-García, P Román Sánchez, E Salcedo, M Navarro, R Ochando

Abstract

Background: Patients with chronic obstructive pulmonary disease (COPD) often present with severe acute exacerbations requiring hospital treatment. However, little is known about the prognostic consequences of these exacerbations. A study was undertaken to investigate whether severe acute exacerbations of COPD exert a direct effect on mortality.

Methods: Multivariate techniques were used to analyse the prognostic influence of acute exacerbations of COPD treated in hospital (visits to the emergency service and admissions), patient age, smoking, body mass index, co-morbidity, long term oxygen therapy, forced spirometric parameters, and arterial blood gas tensions in a prospective cohort of 304 men with COPD followed up for 5 years. The mean (SD) age of the patients was 71 (9) years and forced expiratory volume in 1 second was 46 (17)%.

Results: Only older age (hazard ratio (HR) 5.28, 95% CI 1.75 to 15.93), arterial carbon dioxide tension (HR 1.07, 95% CI 1.02 to 1.12), and acute exacerbations of COPD were found to be independent indicators of a poor prognosis. The patients with the greatest mortality risk were those with three or more acute COPD exacerbations (HR 4.13, 95% CI 1.80 to 9.41).

Conclusions: This study shows for the first time that severe acute exacerbations of COPD have an independent negative impact on patient prognosis. Mortality increases with the frequency of severe exacerbations, particularly if these require admission to hospital.

References

    1. Chest. 1995 May;107(5):1193-8
    1. JAMA. 1995 Dec 20;274(23):1852-7
    1. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):959-67
    1. Am J Respir Crit Care Med. 1999 Dec;160(6):1856-61
    1. Chest. 2000 Feb;117(2):398-403
    1. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):381-90
    1. BMJ. 2000 May 13;320(7245):1297-303
    1. Chest. 2000 Nov;118(5):1278-85
    1. Am J Respir Crit Care Med. 2001 Aug 1;164(3):358-64
    1. Arch Bronconeumol. 2001 Oct;37(9):375-81
    1. Chest. 2002 May;121(5):1434-40
    1. Chest. 2002 May;121(5):1441-8
    1. Thorax. 2002 Sep;57(9):759-64
    1. Am J Respir Crit Care Med. 2002 Sep 1;166(5):680-5
    1. Thorax. 2002 Oct;57(10):847-52
    1. Eur Respir J. 2002 Oct;20(4):819-25
    1. Lancet. 2003 Feb 8;361(9356):449-56
    1. Am J Respir Crit Care Med. 2003 Feb 15;167(4):544-9
    1. Am J Respir Crit Care Med. 2003 Apr 15;167(8):1090-5
    1. Thorax. 2003 May;58(5):399-404
    1. Chest. 2003 Aug;124(2):459-67
    1. Eur Respir J. 2003 Dec;22(6):931-6
    1. N Engl J Med. 2004 Mar 4;350(10):1005-12
    1. Eur Respir J. 2004 Aug;24(2):206-10
    1. Am Rev Respir Dis. 1969 Jun;99(6):865-71
    1. Am Rev Respir Dis. 1986 Jan;133(1):14-20
    1. Bull Eur Physiopathol Respir. 1986 May-Jun;22(3):217-24
    1. J Chronic Dis. 1987;40(5):373-83
    1. Am J Med. 1995 Mar;98(3):272-7
    1. Lancet. 1997 May 3;349(9061):1269-76
    1. Eur Respir J. 1997 Dec;10(12):2794-800
    1. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418-22
    1. Respir Med. 1999 Mar;93(3):173-9
    1. N Engl J Med. 2005 Jul 14;353(2):123-32
    1. N Engl J Med. 2005 Jul 14;353(2):133-44

Source: PubMed

3
Abonneren